Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study.

Annals of the rheumatic diseases·2024
Same author

One-year outcomes of same-day-discharge robot-assisted radical prostatectomy.

BJU international·2024
Same author

Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.

World journal of urology·2024
Same author

How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group.

BJU international·2024
Same author

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31].

European urology·2024
Same author

Complications of immuno-oncology care: what urologist should know.

BJU international·2024

Related Experiment Videos

Systemic juvenile idiopathic arthritis.

Alberto Martini1

  • 1Dipartimento di Pediatria, Università di Genova, Pediatria II e Reumatologia, Istituto G Gaslini, Genova, Italy. albertomartini@ospedale-gaslini.ge.it

Autoimmunity Reviews
|August 14, 2012
PubMed
Summary

Systemic juvenile idiopathic arthritis (sJIA) is distinct from other JIA forms due to its autoinflammatory nature. Targeting interleukin-6 and interleukin-1 offers new therapeutic strategies and may improve long-term outcomes for sJIA patients.

Related Experiment Videos

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Autoinflammatory Diseases

Background:

  • Systemic juvenile idiopathic arthritis (sJIA) presents unique clinical and etiological features compared to other forms of juvenile idiopathic arthritis (JIA).
  • Evidence suggests sJIA has a significant autoinflammatory basis, differentiating it pathologically.
  • Key pro-inflammatory cytokines, specifically interleukin-6 (IL-6) and interleukin-1 (IL-1), are implicated in sJIA pathogenesis.

Purpose of the Study:

  • To highlight the distinct etiopathogenesis of sJIA.
  • To underscore the role of IL-6 and IL-1 in sJIA.
  • To explore the potential impact of targeted cytokine inhibition on sJIA treatment and prognosis.

Main Methods:

  • Review of existing literature on sJIA pathogenesis.
  • Analysis of the role of specific cytokines in inflammatory pathways.
  • Discussion of emerging therapeutic strategies targeting IL-6 and IL-1.

Main Results:

  • sJIA is etiopathogenically distinct from other JIA subtypes.
  • IL-6 and IL-1 play a central role in the inflammatory processes of sJIA.
  • Targeting these cytokines represents a promising therapeutic avenue.

Conclusions:

  • The distinct nature of sJIA warrants specific therapeutic approaches.
  • Inhibition of IL-6 and IL-1 is poised to significantly alter sJIA management.
  • This targeted therapy may lead to improved long-term prognoses for individuals with sJIA.